Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

Bio-IT World August 18, 2004 Mark D. Uehling	Master of the EDC Universe An interview with Sylva Collins, global head of advanced clinical systems at Novartis, who in the case of electronic data capture (EDC), proved to the pharmaceutical industry that technology could be transformative in clinical trials.
Bio-IT World Dec 2006/Jan 2007	Briefs Screening Sold... Belgian Acquisition... Edc Master... Astellas Licenses... etc.
Bio-IT World August 18, 2004 Anthony Strattner	Opportunity to Gain or Lose A keynote speaker at Best Practices ceremony asserts that drug-development science -- those activities that go beyond translational science and into product testing and commercialization -- has stagnated, causing a pipeline problem.
Bio-IT World October 2006 Mark D. Uehling	Datasci Suits Threaten Industry The U.S. Patent Office is under scrutiny in a series of lawsuits that are baffling the world of clinical trial technology.
Bio-IT World March 17, 2004	Strategic Insights Clinical Trials Major drug developers have put electronic data capture to the test and found benefits ranging from instant data access to fewer truckloads of paper. Yet many clinical sites are slow to accept the technology.
Bio-IT World March 17, 2004 Paul Bleicher	Winning at EDC Implementation Adoption may be lagging at the enterprise level, but there's a stalwart group of biopharmas making EDC happen. Here's how they're doing it
Pharmaceutical Executive July 1, 2006 Jeannette Park	Roundtable: Are We There Yet? How About Now? Now? Can Electronic Data Capture become the industry standard for clinical trials? In this roundtable discussion, six early adopters reveal where they struggled, and what you need to know to implement this new technology.
Bio-IT World January 13, 2003 Mark D. Uehling	Powerhouse CRO (Slowly) Goes Electronic Unhappy customers at Quintiles -- the world's largest CRO (contract research organization) -- are rare. It kept plugging away at the startup process, redesigning it from scratch. Now starting electronic trials takes no longer than paper ones.
Bio-IT World February 2007 Beth Harper	Meshing EDC with CTMS Many unsolved problems in conducting clinical trials cause delays, wasted resources, team frustration, and even safety issues. Thus, the industry is turning more of its attention away from Electronic Data Capture to Clinical Trial Management Systems.
Bio-IT World July 2005 Mark D. Uehling	'E-source' Is Coming, Experts Say The odd marriages of the ancient and modern in clinical technologies were in evidence at the E-Clinical Trials & Research conference program. There was evidence of the adoption of advanced and robust commercial software -- even toward clinical trials that do not use paper, though most do.
The Motley Fool October 31, 2006 Brian Gorman	Kendle's New Risk The drug development services company continues to deliver, but new debt poses some risk to future earnings. In the near term, investors could be in for a bumpy ride.
Bio-IT World July 2005 David Fishbach	Does EDC Herald the End of CTMS? Clinical trial managements systems (CTMSs) and Electronic data capture systems (EDCs) are compared with respect to their history, advantages and disadvantages. Studies suggest both have enough advantages to survive in some form of integrated solution.
The Motley Fool April 20, 2011 Brandon Glenn	Growing CRO Demand Boosts Outlook for Kendle It's been rough going lately for Kendle.
Bio-IT World February 2006 Chris Connor	Has EDC Jumped the Shark? As data management teams begin to deploy electronic data capture in their clinical trials, "cool" gives way to the cool reality that IT investments have to produce real results.
Bio-IT World May 9, 2003 Mark D. Uehling	Data Rapture? Electronic capture of data: Some say it unclogs the medieval clinical trials process. Others remain skeptical of software and put their trust in paper.
Bio-IT World October 2005 Mark D. Uehling	Phase Forward Acquires Lincoln Technologies As the most intriguing clinical trial technology deal of the year, the acquisition demonstrates both Phase Forward's financial resources and the appeal of Lincoln Technologies' Java- and Web-based tools for the analysis and visualization of drug safety.
Bio-IT World May 19, 2004 Mark Uehling	Patients Without Borders As biotech companies search for patients abroad, technology clearly matters--but not every clinical trial on the planet is ready for electronic data capture.
Bio-IT World March 10, 2003 Kenneth Getz	E-Clinical Technology Overview Clinical trial researchers want to leverage the benefits of IT -- and now they can for every core process. But they also have to get past the barriers to adoption.
Bio-IT World June 2006 Mark D. Uehling	Afferenz on EDC, Images, and Data Integration There are people who think the outsourcing of IT to India will not affect the life sciences. But companies like Afferenz raises concerns about U.S. companies lagging behind Indian companies on laying the foundation for clinical trials.
Bio-IT World Dec 2006/Jan 2007 Deborah Borfitz	Rave Review for Medidata's Asian EDC Advantage Tokyo-based Astellas Pharma will use Medidata's Rave 5.5 for all its global clinical studies over the next five years. Another new biopharma customer for Rave is AstraZeneca.
Bio-IT World March 17, 2004	Speeding EDC Adoption Implementation by clinical sites is lumbering along at an unimpressive rate. Here's what must be done to speed things up
The Motley Fool April 24, 2009 Robert Steyer	Nothing to CRO About The good times have stopped rolling for Contract research organizations, as they warn of unexpected contract cancellations and reduced demand for services.
Bio-IT World Dec 2006/Jan 2007 John Mestler	e-Harmony: EDC and e-Health Records Bringing bio-pharmaceutical requirements to the table with government eHealth designers in the US, EU, and around the world is the beginning of the necessary fusion of electronic health records and electronic data capture.
The Motley Fool February 14, 2006 Brian Gorman	Kendle's on Solid Ground The contract research services outfit is on track for another good year. Investors, take note.
Bio-IT World Dec 2005/Jan 2006 Mark D. Uehling	Convergence of EHR and EDC The hypothesized convergence of applications and databases for drug development, clinical trials, hospitals, and physicians is both closer and more distant.
Bio-IT World May 2006 Nick Richards	The Unifying Power of Ajax Asynchronous JavaScript and XML (Ajax) will simplify the collecting of clinical trials data. As the pharmaceutical industry and contract research organizations moves toward electronic data capture, Ajax technology can smooth the way.
Bio-IT World Jul/Aug 2006 Mark D. Uehling	RIP, Data Managers? Do people working in data management at drug discovery firms have a future?
Bio-IT World March 10, 2003 Spink & Blumenstiel	Getting IT Right Applying information technology to trials can boost productivity. Here's a strategic framework for going e-clinical.
Bio-IT World November 2006 Mark D. Uehling	Putting EDC on the Fast Track There's no escaping the imposing numbers of choices in launching a clinical trial using electronic data capture. Is there a better way? Clinical trial consultant Fast Track Systems says it has one.
Bio-IT World May 2006 Mark D. Uehling	Clinical Speakers Enjoy Industry Acceptance For the first time at the Bio-IT World Conference, the clinical speakers did not wring their hands about whether their tools would be accepted by the industry. This year, it was a question of how quickly technology would be used to expedite trials and raise the quality of the data therein.
CIO December 1, 2002 Edward Prewitt	The Utility of Humility Think you know what leadership is? Management guru Jim Collins might beg to differ.
Bio-IT World March 17, 2004 Kenneth Getz	Getting Past No Low adoption rates of e-clinical trial technology can't be blamed on external market dynamics alone. Biopharmas must face four inhibitors within their own organizations
Bio-IT World November 2005 Mark D. Uehling	The Unstoppable Swiss At a time when other pharmaceutical giants struggle to justify pediatric uses of their medicines, or to defend themselves against thousands of lawsuits, Novartis has one of the safest and strongest pipelines in the industry.
PHONE+ Cary Bush	Phone Plus Reads Good to Great In "Good to Great," author Jim Collins and his research team set out to find how "good" companies become "great."
The Motley Fool November 1, 2005 Brian Gorman	Kendle's Resurgence Can the contract pharmaceutical researcher continue its growth without more acquisitions? Despite the vibrant growth and its operational progress, Kendle still is at a disadvantage to larger rivals like Charles River Laboratories and PPD.
Pharmaceutical Executive February 1, 2011 Jill Wechsler	The Building Block of Drug Discovery With Francis Collins now calling the shots at NIH, will be be able to deliver on the innovations behind the genome?
Pharmaceutical Executive June 1, 2011	Filling in the Bigger Picture Part II of The Avoca Group's 2011 CRO survey on clinical development outsourcing relationships.
Bio-IT World November 19, 2004 Mark D. Uehling	Safety Last? Antiquated reporting of adverse events in clinical trials is costing pharma billions and forcing it to seek new pharmacovigilance solutions.
Pharmaceutical Executive November 1, 2006	Unraveling the eSource Industry-wide standards for electronic patient data have long felt like buried treasure. Companies today are getting closer - by way of a tangled map.
The Motley Fool April 28, 2006 Brian Gorman	Kendle Stays Hot The small contract research outfit seems like a safe bet in the near term, but investors should closely monitor the firm's performance.
Pharmaceutical Executive July 1, 2005 Rob Case	In Search of the Holy Grail Chasing ultimate clinical trial efficiency, one small step at a time. A carefully considered approach to data integration can benefit every stakeholder from the investigator to the pharmaceutical executive.
Bio-IT World March 2006	News Blast Merck/Phase Forward... Curbing a Pandemic... Focused Trials... Collaboration...
Bio-IT World August 2005 Ellen H. Julian	Tech Expertise Singles Out Outsourcers Biopharmaceutical companies are flocking to consultants, outsourcers, and staffing firms to help with discrete clinical trial processes to gain access to advanced technologies and reduce the drain on already-scarce IT resources.
Bio-IT World January 21, 2005 Sprouse & Shiple	Strategic Insights: Building Integrated Research Networks Uniting a region's medical centers on clinical projects could create a new model for clinical trials.
CIO October 1, 2002 Edward Prewitt	Leadership Makes Technology Work Management guru Jim Collins talks about turning the possible into the practical.
The Motley Fool February 15, 2005 Brian Gorman	Kendle Grows With Client Base The contract drug research company shares surged as the firm showed signs of new life.
Bio-IT World June 2006 Mark D. Uehling	Real-Time Trials Currently, there is more visibility into the precise location of a FedEx package than the progress of a multimillion-dollar clinical drug trial. But adaptive design trials are changing that.
Pharmaceutical Executive October 1, 2011 Jill Wechsler	Guiding a Revolution in Science Francis Collins led the genomic revolution as director of the International Human Genome Project and director of the National Human Genome Research Institute (NHGRI) at the NIH from 1993 to 2008.
Bio-IT World October 2006 William Claypool	The Perfect Circle With the most current technologies accelerating adaptive trial designs, the future holds great promise.